Semaglutide is mostly effectively tolerated with very similar dropout costs when put next with placebo, even though it might be less very well tolerated than dulaglutide (Trulicity).1,3 The most common adverse outcomes are nausea, vomiting, and diarrhea and will be knowledgeable by about thirty%